NCT02133469View on ClinicalTrials.gov

PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae

NACompletedINTERVENTIONAL
Enrollment

3,281

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Streptococcal PneumoniaNasopharyngeal DiseasesVaccination Adverse Event
Interventions
BIOLOGICAL

PCV7 (Pneumococcal 7-Valent Conjugate Vaccine)

injection 0.5 mL, single dose

BIOLOGICAL

Hib Vaccine

Single Dose

Trial Locations (9)

100120

Xicheng District Center for Disease Prevention and Control, Xicheng District

101400

Huairou District Center for Disease Prevention and Control, Beijing

102600

Daxing District Center for Disease Prevention and Control, Beijing

Unknown

Chongwen District Center for Disease Control and Prevention, Beijing

Shijingshan District Center for Disease Control and Prevention, Beijing

Xuanwu District Center for Disease Control and Prevention, Beijing

Chaoyang District Center for Disease Control and Prevention, Chaoyang District

Dongcheng District Center for Disease Control and Prevention, Dongcheng District

Fengtai District Center for Disease Control and Prevention, Fengtai District

All Listed Sponsors
collaborator

Beijing Municipal Health Bureau

OTHER

collaborator

Beijing Center for Disease Control and Prevention

OTHER_GOV

lead

Centers for Disease Control and Prevention, China

OTHER_GOV

NCT02133469 - PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae | Biotech Hunter | Biotech Hunter